Cabaletta Bio

biopharmaceutical company focused on the discovery and development of cellular therapies for B cell-mediated autoimmune diseases. .

Launch date

Jun 2017

Employees

Market cap

Enterprise valuation

AUD8m (Public information from Sep 2024)

Radnor Township Pennsylvania (HQ)

https://www.cabalettabio.com/

https://twitter.com/cabalettabio https://www.linkedin.com/company/cabalettabio

Authorizing premium user...